National and Kapodistrian University of Athens
Μελέτη του οστικού μεταβολισμού της αγγειογένεσης και των εκφραζόμενων χυμοκινών σε ασθενείς με πρωτοπαθή συστηματική (AL) αμυλοείδωση
Abstract
dc:descriptionThe term "amyloidosis" describes a large class of disease entities attributable to protein deficiency to obtain a functional quaternary structure and relates to the conversion of peptides or proteins from soluble functional forms to fibrous degradation derivatives with secondary β-sheet structure. The most common form is primary systemic AL amyloidosis with an incidence estimated at around 8.9 cases per million population per year. Angiogenesis and bone metabolism have been studied in many malignancies for their role in the progression and prognosis of these diseases. The primary objective of this study is to study the biochemical model of bone metabolism and angiogenesis in patients with first-line AL primary systemic amyloidosis. Angiogenesis plays an important role in the progression of multiple myeloma, and is a component of complex interactions between the plasmatic cell and the microenvironment, and its expression is regulated by a plurality of molecules. Serum angiogenic serum cytokines have already been studied in multiple myeloma patients, have been found to be elevated and have been associated with the disease stage (132). In addition, they seem to be involved in the homeostasis of several organs such as renal glomerule, endothelium and peripheral nervous system, and potentially could have prognostic significance in patients with AL amyloidosis. Such data are not available. For this reason, the angiogenic cytokines were measured in this work and the possible correlations with the characteristics of the disease, the involvement of the target organs and the progression of the disease were analyzed. Correspondingly, bone metabolism is extremely disturbed in patients with multiple myeloma with predominant bone decomposition component and suppression of bone production. Bone metabolism has not been systematically studied in patients with primary systemic AL amyloidosis. The purpose of this prospective study is to evaluate bone metabolism in newly diagnosed patients and to compare the results with those with other plasma cell dyscrases such as multiple myeloma and monoclonal gammopathy of unspecified significance as well as to investigate possible correlations with the characteristics of the disease and Survival. Data from measurements of bone formation, bone degradation and angiogenic cytokines in serum of 102 patients with primary systemic amyloidosis were analyzed. Measurements were made by the ELISA method. The statistical analysis was done with the SPSS20 program.The results of this study support the presence of increased bone resorption and osteoclastic activity that is fully contrasted in patients with primary systemic AL amyloidosis. This also explains the absence of osteology in these patients. Elevated levels of osteoprotegerin in patients with AL amyloidosis are correlated independently with the prognosis of the disease and this association is independent of the Mayo Staging. This suggests that elevated levels of osteoprotegerin not only reflect the achievement of balance with increased osteoclastic activity but also the early onset of heart failure as well as generalized vascular and endothelial damage coexisting in patients with AL amyloidosis. The results of this study underline the role of osteoprotegerin in the biology of the disease and suggest the possible wider use of this useful biomarker as a prognostic factor. Serum angiogenic cytokine levels measured in this study were elevated in patients with AL amyloidosis compared to both healthy controls and patients with multiple myeloma. This is probably the result of the indirect or immediate action of amyloid fibrils or light chains or a counter-response to organ dysfunction. The large differences between the two diseases are indicative of the different pathophysiology of the two diseases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gavriatopoulou, Maria
- Γαβριατοπούλου, Μαρία
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/35577